thyroid issues with glp 1 GLP-1 medications and disease deserve nuance., Current human data do not show a meaningful increase in thyroid cancer risk., If thyroid antibodies improve, that’s almost always a byproduct of Glucagon-like peptide 1 receptor agonist

Xie, Y et al Glucagon-like peptide 1 receptor agonist discontinuation and risks of major adverse cardiovascular events in adults with type 2 diabetes: target trial emulation BMJ Medicine, March 18, 2026

There remains an unmet need for weight-management medications that can facilitate nonsurgical, sustained weight reduction and reduce pain in persons with obesity-related knee osteoarthritis, they added

Two additional groups were also injected intraperitoneal (IP) 2.5 g/kg b.wt

Other researchers who are also interested in buckwheat have reported beneficial effects

GLP-1 receptor agonists have great therapeutic potential for treating diabetes and obesity

Finding the right treatment at a price you can manage shouldn't add to that stress